Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil

Annual vaccination against influenza is the best tool to prevent deaths and hospitalizations. Regular updates of trivalent inactivated influenza vaccines (TIV) are necessary due to high mutation rates in influenza viruses. TIV effectiveness is affected by antigenic mismatches, age, previous immunity...

書誌詳細
出版年:	Viruses
主要な著者:	Artur Capão, Maria L. Aguiar-Oliveira, Braulia C. Caetano, Thayssa K. Neves, Paola C. Resende, Walquiria A. F. Almeida, Milene D. Miranda, Olindo A. Martins-Filho, David Brown, Marilda M. Siqueira, Cristiana C. Garcia
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-07-01
主題:	influenza vaccine immunogenicity seroprotection seroconversion Brazil
オンライン･アクセス:	https://www.mdpi.com/1999-4915/14/8/1692

類似資料

Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study
著者:: Kunal Kumar, 等
出版事項: (2024-03-01)

Reactogenicity, safety, and immunogenicity of a quadrivalent seasonal influenza vaccine in adults aged 65 years and older: Phase 4 study results from India during December 2023–February 2024
著者:: Vishal Jain, 等
出版事項: (2025-12-01)

Correlation of Frailty Status with Influenza Vaccine Seroconversion and Seroprotection among Elderly Population
著者:: Sukamto Koesnoe, 等
出版事項: (2016-12-01)

The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
著者:: Caroline Van Den Ende, 等
出版事項: (2017-08-01)

H5N1 highly pathogenic avian influenza vaccination: Seroresponse of mexican poultry in the 2022–2024
著者:: Brenda Aline Maya Badillo, 等
出版事項: (2025-10-01)

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction
著者:: Yongji Wang, 等
出版事項: (2020-10-01)

Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel
著者:: Hanie Mahdiani, 等
出版事項: (2014-11-01)

Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
著者:: Kuan-Yin Lin, 等
出版事項: (2023-12-01)

The immunogenicity of GSK’s recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience
著者:: Caroline van den Ende, 等
出版事項: (2017-08-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
著者:: Rodrigo Luiz Carregaro, 等
出版事項: (2023-08-01)

Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis
著者:: Xiting Dai, 等
出版事項: (2019-06-01)

Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents
著者:: Eun Kyeong Kang, 等
出版事項: (2017-04-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
著者:: Zhaojun Mo, 等
出版事項: (2017-06-01)

Optimizing hepatitis B vaccination in chronic kidney disease: a comprehensive scoping review of strategies across CKD stages, dialysis, and transplant populations
著者:: Wiwat Chancharoenthana, 等
出版事項: (2025-12-01)

Immunogenicity and safety of the booster COVID-19 vaccine among people with HIV: a systematic review and meta-analysis
著者:: Zhenzhen Chen, 等
出版事項: (2025-09-01)

Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial
著者:: Roseane P. Medeiros, 等
出版事項: (2023-03-01)

Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
著者:: Sandrine I. Samson, 等
出版事項: (2019-03-01)

An Inactivated West Nile Virus Vaccine Candidate Based on the Lineage 2 Strain
著者:: Mikhail F. Vorovitch, 等
出版事項: (2024-12-01)

A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants
著者:: Lalitendu Mohanty, 等
出版事項: (2017-09-01)

Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial
著者:: Anand Prakash Dubey, 等
出版事項: (2017-09-01)

Seroprotection after hepatitis B vaccination in chronic kidney disease patients with modified schedule and dosage
著者:: Shireen Siddiqui, 等
出版事項: (2010-05-01)

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy
著者:: M. M. Baranova, 等
出版事項: (2024-06-01)

Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
著者:: Cecilia Montalban, 等
出版事項: (2018-03-01)

Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults
著者:: Ahmed Tawfik, 等
出版事項: (2023-12-01)

Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants
著者:: Songa Narayana Rao, 等
出版事項: (2025-09-01)

Smallpox Vaccine LC16m8: Production, Properties, and Prospects
著者:: L. F. Stovba, 等
出版事項: (2024-10-01)

Immunogenicity of COVID-19 vaccination in kidney transplant recipients
著者:: V S Jibia, 等
出版事項: (2023-01-01)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
著者:: Yaping Chen, 等
出版事項: (2022-12-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
著者:: Yuemei Hu, 等
出版事項: (2019-05-01)

Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine
著者:: Francisco Noé Fonseca, 等
出版事項: (2023-08-01)

Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
著者:: Houda Haban, 等
出版事項: (2017-09-01)

Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease
著者:: Yan Li, 等
出版事項: (2021-09-01)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
著者:: Sanjay K. Lalwani, 等
出版事項: (2017-01-01)

An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participants
著者:: Sanjay Vasant Mankar, 等
出版事項: (2025-12-01)

Immunogenicity of COVID‐19 mRNA vaccines in hemodialysis patients: Systematic review and meta‐analysis
著者:: Shahab Falahi, 等
出版事項: (2022-11-01)

Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
著者:: Kei Nakashima, 等
出版事項: (2017-03-01)

Immunogenicity profile after COVID-19 vaccination in patients with onco-hematological diseases
著者:: João Bosco de Almeida Neto, 等
出版事項: (2023-03-01)

A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam
著者:: Phan Trong Lan, 等
出版事項: (2019-12-01)

Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®
著者:: Mathilde Latreille-Barbier, 等
出版事項: (2017-11-01)

Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis
著者:: Mayuri Gogoi, 等
出版事項: (2024-01-01)